Biotech Hunter

3 Questions Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Stock Owners Need Answered

By: Liam Hunter - March 28, 2017 2:43 AM

Addressing SGYP stock recent decline, Trulance sales trajectory, and short-term risks facing Synergy Pharmaceuticals Inc (NASDAQ:SGYP).

Also posted in Healthcare & Biotech, Members

Taro Pharmaceutical Industries Ltd (NYSE:TARO) Stock Prospects With Trump & Sun In Charge

By: BNL Staff - March 24, 2017 2:43 AM

Does Sun Pharmaceutical ownership of Taro Pharmaceutical Industries Ltd (NYSE:TARO) make TARO stock a bad investment?

Also posted in Members, Request Coverage

Assessing Nektar Therapeutics (NASDAQ:NKTR) Stock & NKTR-181 Commercial Outlook After 42% Move

By: Liam Hunter - March 20, 2017 2:43 AM

Is NKTR stock still a good buy after its 40% move higher, after Nektar Therapeutics (NASDAQ:NKTR) strong NKTR-181 data?

Also posted in Healthcare & Biotech, Members, Request Coverage

Is Celldex Therapeutics (NASDAQ:CLDX) The Next TG Therapeutics Inc (NASDAQ:TGTX) Stock

By: Liam Hunter - March 7, 2017 2:43 AM

Prior to this week, TG Therapeutics (NASDAQ:TGTX) and TGTX stock looks a lot like Celldex Therapeutics (NASDAQ:CLDX) or CLDX stock.

Also posted in Healthcare & Biotech, Members

Is Celldex Therapeutics (CLDX) Stock the Next Clovis Oncology (CLVS)?

By: Liam Hunter - February 25, 2017 2:43 AM

Will Celldex Therapeutics succeed with Glembatumab vedotin at treating triple negative breast cancer patients to make CLDX stock the next CLVS stock?

Also posted in Healthcare & Biotech, Members

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Stock Outlook Improves Behind Trulance Catalysts & Recent Developments

By: Liam Hunter - February 23, 2017 2:43 AM

SGYP stock may finally be a good buy after Synergy Pharmaceuticals offering, Linzess’ label change, and smart recruiting from Valeant Pharmaceuticals

Also posted in Healthcare & Biotech, Members